Clinical Trials Directory

Trials / Unknown

UnknownNCT02837419

Cost-effectiveness of Extracorporeal Life Support Treatment

A Multicenter Prospective Observational Cohort Study Determining the Cost-effectiveness of Extracorporal Life Support (ECLS) Treatment

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
University Medical Center Groningen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study evaluates patients on ECLS treatment as considered appropriate with mortality and health related Quality of life and costs.

Detailed description

A direct comparison between usual care and ECLS treatment is difficult. Alternatively we compare predicted mortality for every patient based on validated scoring systems at the initiation of ECLS treatment with the actual outcome, so every patient is his own control. Primary outcome is HRQoL assessed with the EQ-5D questionnaire at 1 year. Healthcare costs and costs from a societal perspective are prospectively measured.

Conditions

Interventions

TypeNameDescription
BEHAVIORALHealth related Quality of life EQ-5DQuality of Care

Timeline

Start date
2017-12-01
Primary completion
2020-01-01
Completion
2020-01-01
First posted
2016-07-19
Last updated
2019-09-25

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT02837419. Inclusion in this directory is not an endorsement.

Cost-effectiveness of Extracorporeal Life Support Treatment (NCT02837419) · Clinical Trials Directory